FIELD: medicine, diagnostics.
SUBSTANCE: the present innovation deals with functional radiation diagnostics of uterine tubes, ureters, bile-excretory pathways and so on. It is necessary to carry out ultrasound research, organ's echocontrasting technique, introduction of sterile hydrogen peroxide solution in nontoxic dosage followed finally by evaluation of the results obtained. Moreover, ultrasound research should be conducted under conditions of local intracavitary anesthesia, either due to endocavitary or transabdominal access in three stages. At the first stage one should fulfill organ's echocontrasting due to introduction of a contrast sound-conducting substance into organ's cavity, fix permeability of the latter into a hollow organ under testing, adjacent organs and cavities, detect the volume and structure of a hollow organ, the availability of pathological neoplasms and evaluate functional state of an organ. At the second stage, organ's echocontrasting should be fulfilled due to introducing a sterile hydrogen peroxide solution directly into a hollow organ, according to gaseous bubbles it is necessary to evaluate anatomical structures, the availability of pathological deviations and echocontrast movement. As for the third stage, it should be carried out about 3-6 min after removing a catheter out of the cavity, due to echocontrasting the organ with residual gaseous bubbles it is possible to evaluate the state of hollow organs according to physiological movement of bubbles along the hollow organ in real period of time followed by introduction of sterile hydrogen peroxide with the help of a catheter applied under conditions of local intracavitary anesthesia, concentration of hydrogen peroxide in solution should be equal to 0.30-0.33%. The innovation enables to detect different pathology of a hollow organ, evaluate both anatomical and physiological alterations in organs.
EFFECT: higher accuracy of detection.
4 cl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSING CHANGES IN MYOMETRIUM | 2006 |
|
RU2307590C1 |
METHOD FOR ULTRASONIC EXAMINATION OF PATIENTS DIAGNOSED WITH ENDOMETRIAL CANCER | 2020 |
|
RU2739108C2 |
METHOD FOR EXPRESS DETERMINATION OF LIVER ALVEOCOCCOSIS ACTIVITY BY ULTRASONIC EXAMINATION WITH ECHO CONTRAST | 2019 |
|
RU2687152C1 |
METHOD FOR DETERMINING THE TIME OF ARTERIAL PHASE FOR ECHO CONTRASTING OF LIVER, KIDNEY AND SPLEEN | 2020 |
|
RU2744825C1 |
METHOD FOR PERFORMING LAPAROSCOPIC MYOMECTOMY | 2022 |
|
RU2808111C1 |
METHOD FOR ASSESSING RENAL VIABILITY BY ULTRASONIC EXAMINATION WITH ECHO CONTRAST IN THE EARLY POSTOPERATIVE PERIOD IN ANURIA AFTER EXTRACORPOREAL NEPHRECTOMY IN THE CONDITIONS OF PHARMACO-COLD ISCHEMIA WITHOUT CROSSING THE URETER WITH ORTHOTOPIC VESSEL REPLANTATION | 2019 |
|
RU2686914C1 |
DEVICE FOR ARREST OF POSTPARTUM HEMORRHAGE | 2009 |
|
RU2440038C2 |
METHOD FOR INTRAOPERATIVE DIFFERENTIAL DIAGNOSTICS OF UTERINE MYOMA AND III DEGREE ADENOMIOSIS WITH UTERINE SIZE OF 12 AND MORE WEEKS OF PREGNANCY | 2016 |
|
RU2634420C1 |
METHOD FOR INTRAOPERATIVE EVALUATION OF RENAL BLOOD SUPPLY AFTER EXTRACORPORAL NEPHRECTOMY IN CONDITIONS OF PHARMACO-COLD ISCHEMIA WITHOUT URETER CROSSING WITH ORTHOTOPIC VESSEL REPLACEMENT BY ULTRASONIC EXAMINATION DATA | 2019 |
|
RU2685920C1 |
METHOD OF ECHOHYSTEROSALPINGOGRAPHY WITH SONOVUE ULTRASOUND CONTRAST AGENT | 2018 |
|
RU2697370C1 |
Authors
Dates
2006-12-27—Published
2005-02-24—Filed